Akèy › Kansè nan tete › Pennsylvania › Lancaster
Etid klinik pou Kansè nan tete nan Lancaster, PA
4 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Lancaster (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Ap rekriteFaz 3
- Penn Medicine - Lancaster General Hospital, Lancaster
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Ap rekriteFaz 3
- Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Lancaster General Ann B Barshinger Cancer Institute, Lancaster
E-Mindfulness Approaches for Living After Breast Cancer
Ap rekriteFaz 3
- Lancaster General Ann B Barshinger Cancer Institute, Lancaster
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Lancaster
- Kansè Poumon ki pa ti selil7 etid
- Maladi kadyovaskilè5 etid
- Ensifizyans kadyak5 etid
- Kansè pwostat4 etid
- Kansè Metastatik4 etid
- Kansè poumon3 etid
- Amblyopi3 etid
- Maladi kè3 etid
- Kansè vejik3 etid
- Kansè Vezik ki pa envazif miskilè3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.